Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.

Abstract

Novel diagnostic tests for TB are potentially highly cost-effective. Cost-effectiveness is maximized by high-specificity, low-cost tests deployed to regions with poor infrastructure.